CXXI Stock Overview
An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
C21 Investments Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.30 |
52 Week High | CA$0.64 |
52 Week Low | CA$0.20 |
Beta | 2.29 |
11 Month Change | 0% |
3 Month Change | -3.23% |
1 Year Change | -10.45% |
33 Year Change | -63.41% |
5 Year Change | -53.13% |
Change since IPO | -98.80% |
Recent News & Updates
Some C21 Investments Inc. (CSE:CXXI) Shareholders Look For Exit As Shares Take 26% Pounding
Nov 12Subdued Growth No Barrier To C21 Investments Inc.'s (CSE:CXXI) Price
Sep 12Recent updates
Some C21 Investments Inc. (CSE:CXXI) Shareholders Look For Exit As Shares Take 26% Pounding
Nov 12Subdued Growth No Barrier To C21 Investments Inc.'s (CSE:CXXI) Price
Sep 12C21 Investments Inc.'s (CSE:CXXI) 30% Share Price Surge Not Quite Adding Up
May 12A Look At The Intrinsic Value Of C21 Investments Inc. (CSE:CXXI)
May 01Some Confidence Is Lacking In C21 Investments Inc. (CSE:CXXI) As Shares Slide 27%
Mar 09Is C21 Investments (CSE:CXXI) A Risky Investment?
Sep 04These 4 Measures Indicate That C21 Investments (CSE:CXXI) Is Using Debt Reasonably Well
Mar 21These 4 Measures Indicate That C21 Investments (CSE:CXXI) Is Using Debt Reasonably Well
Nov 29C21 Investments Inc. (CSE:CXXI) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
Oct 12A Look At The Fair Value Of C21 Investments Inc. (CSE:CXXI)
Apr 22Does C21 Investments (CSE:CXXI) Have A Healthy Balance Sheet?
Mar 22C21 Investments' (CSE:CXXI) Solid Earnings May Rest On Weak Foundations
Oct 05We Think C21 Investments (CSE:CXXI) Can Stay On Top Of Its Debt
Sep 03C21 Investments (CSE:CXXI) Seems To Use Debt Quite Sensibly
Mar 07Shareholder Returns
CXXI | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | 1.7% | -2.4% | 0.4% |
1Y | -10.4% | -22.8% | 21.4% |
Return vs Industry: CXXI exceeded the Canadian Pharmaceuticals industry which returned -22.8% over the past year.
Return vs Market: CXXI underperformed the Canadian Market which returned 21.4% over the past year.
Price Volatility
CXXI volatility | |
---|---|
CXXI Average Weekly Movement | 17.3% |
Pharmaceuticals Industry Average Movement | 11.6% |
Market Average Movement | 8.3% |
10% most volatile stocks in CA Market | 17.7% |
10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: CXXI's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: CXXI's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | 114 | Sonny Newman | www.cxxi.ca |
C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk, wholesale, and packaged flowers; edibles; pre-rolls; tinctures; and topicals. It also provides payroll and benefits services.
C21 Investments Inc. Fundamentals Summary
CXXI fundamental statistics | |
---|---|
Market cap | CA$32.41m |
Earnings (TTM) | -CA$431.50k |
Revenue (TTM) | CA$37.45m |
1.0x
P/S Ratio-83.5x
P/E RatioIs CXXI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CXXI income statement (TTM) | |
---|---|
Revenue | US$26.79m |
Cost of Revenue | US$17.58m |
Gross Profit | US$9.21m |
Other Expenses | US$9.52m |
Earnings | -US$308.63k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0026 |
Gross Margin | 34.38% |
Net Profit Margin | -1.15% |
Debt/Equity Ratio | 3.7% |
How did CXXI perform over the long term?
See historical performance and comparison